Home  »  Companies   »  Analysts Say You Should Still Hold OPKO Health Inc...

Analysts Say You Should Still Hold OPKO Health Inc. (NASDAQ: OPK)

OPKO Health Inc. (NASDAQ:OPK) traded at $1.47 at last check on Wednesday, November 23, made an upward move of 0.01% on its previous day’s price.

Looking at the stock we see that its previous close was $1.47 and the beta (5Y monthly) reads 1.73 with the day’s price range being $1.43 – $1.57. In terms of its 52-week price range, OPK has a high of $5.25 and a low of $1.43. The company’s stock has lost about -18.33% over that past 30 days.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.


OPKO Health Inc. has a market cap of $1.14 billion and is expected to release its quarterly earnings report on Feb 22, 2023 – Feb 27, 2023. Estimates by analysts give the company expected earnings per share (EPS) of -$0.08, with the EPS growth for the year raised at -$0.41 for 2022 and -$0.18 for next year. These figures represent -720.00% and 56.10% growth in EPS for the two years respectively.

Analysts tracking the company’s growth have also given it a consensus growth in revenue estimated at $183.51 million, with a low of $166.5 million and a high of $215.8 million. The median projection represents growth adding up to -52.40% compared to sales growth for the corresponding quarter a year ago. According to analyst consensus estimates figures, the company’s yearly revenue forecast for 2022 is expected to hit $995.61 million, or -43.90% down from figures reported last year.

There have been no upward and no downward revisions for the stock’s EPS in last 7 days, something that reflects the nature of company’s price movement in short term. On the other hand, looking at the outlook for the OPK stock, short term indicators assign the stock an average of 100% Sell, while medium term indicators assign it an average of 100% Sell. Long term indicators on average place the stock in the category of 100% Sell.

Based on estimates by 5 analysts, where scores have ranged from 1.00 for a strong buy to 5.00 for a strong sell, 1 have rated the OPKO Health Inc. (OPK) stock as a Hold, while 4 rate it as a Buy. 0 analyst(s) rate it as overweight while 0 of them rated it as underweight, whereas 0 suggest the stock as a Sell. The stock has an overall rating of Buy and investors could take advantage and scoop up stock of the company.

Looking further, we note the current price level is -15.39% off its SMA20 and -18.82% from its 50-day simple moving average. The RSI (14) is pointing at 32.99 while the volatility over the past week is 5.90% and jumps to 6.16% over the past one month. The beta value is 1.69, while the average true range (ATR) is currently pointing at 0.11. The average price target for the stock over the next 12 months is $5.44, with the estimates having a low of $3.50 and a high of $8.50. These price ends are -138.1% and -478.23% off the today’s price level respectively, although investors could be excited at the prospect of a -231.97% if the OPK share price touches on the median price of $4.88.

Let’s briefly compare OPKO Health Inc. (OPK) stock to its peers. We find that today’s price change of 0.01% and -65.57% over the past 12 months for OPK competes that of Johnson & Johnson (JNJ), which has seen its stock price fall -0.13% in the latest trading session and is 10.72% over the last one year. Another of its peers Bristol-Myers Squibb Company (BMY) has dropped -0.06% today, and was 38.25% up over the past year, while Regeneron Pharmaceuticals Inc. (REGN) is also down -1.25% yet, while its price remains in the green at 16.41% over the same period. In contrast to these companies, both the S&P 500 Index and the Dow Jones Industrial are today at 0.51% and 0.24%, respectively, in early deals.

Coming back to OPKO Health Inc. (NASDAQ:OPK), we note that the average 3-month trading volume was 2.29 million, while that of the preceding 10-day period stands at 2.76 million. Current shares outstanding are 750.40 million.

The insiders hold 0.40% of the company’s shares while institutions hold 24.70%. The data shows that short shares as of Oct 13, 2022, stood at 37.44 million at a short ratio of 16.95. This represents a 4.85% short interest in shares outstanding on Oct 13, 2022. Shares short fall in October from the previous month at 38.15 million. Investors should be excited about this stock as its upside potential is great, with today’s price pushing the stock -69.44% down in year-to-date price movement.

Leave a Comment

Your email address will not be published. Required fields are marked *